By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Three Clinical Insights from Landmark Lung Cancer Surgery Study

Three Clinical Insights from Landmark Lung Cancer Surgery Study

GMJ
Last updated: 14/07/2026 03:17
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Medical illustration showing lung surgery outcomes comparison between smoking and non-smoking patients
New research from University of Cincinnati shows lung cancer patients who continue smoking before surgery have higher pulmonary complications but similar short-term mortality rates to those who quit. The findings may influence surgical decision-making for patients unable to stop smoking. — Photo by Aakash Dhage on Unsplash (Unsplash License)
SHARE
1 min read|136 words

The University of Cincinnati’s research on lung cancer surgery outcomes provides three critical findings for clinical practice. First, short-term mortality rates remain similar between patients who continue smoking and those who quit before surgical resection, suggesting smoking status alone should not determine surgical candidacy. Second, current smokers experience demonstrably higher pulmonary complications, including pneumonia and respiratory failure, requiring enhanced perioperative surveillance and intervention protocols. Third, these findings suggest that smoking cessation, while clinically desirable, may not be a mandatory prerequisite for surgical consideration in lung cancer patients—a paradigm shift that could expand access to potentially life-saving procedures. Clinicians should use these insights to individualize surgical decision-making, weighing complication risks against the benefits of timely surgical intervention. The data support a more nuanced approach to preoperative smoking status assessment. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Continued smoking before lung cancer surgery increases pulmonary complications but not short-term mortality →

Related reference
  • Lung Cancer · Condition
  • Pneumonia · Condition
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Correction issued for MAGE-A4/A8 immunotherapy trial in advanced solid tumours

Nature Medicine has published an author correction to a phase 1 trial…

Jackfruit-derived biomaterial shows promise in reversing severe gum disease damage

A composite biomaterial combining jackfruit latex, pomegranate peel extract, and simvastatin has…

Scientists Reprogram Brain Immune Cells to Combat Alzheimer’s Disease

Researchers have identified a molecule called OLE that restores protective function in…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical illustration showing gene therapy delivery to brain regions affected by Parkinson's disease

Dual-Enzyme Gene Therapy Marks New Era in Parkinson’s Treatment

By
Prof. Giorgi Pkhakadze
13/07/2026
Scientific illustration showing CAR-T cells attacking cancer with molecular pathway highlighted

Takeaway: Single protein discovery could unlock CAR-T cell therapy’s full potential

By
Prof. Giorgi Pkhakadze
06/07/2026
Chart showing divergent STI trends in England with herpes cases rising

What England’s Rising Herpes Cases Mean for Your Sexual Health

By
Prof. Giorgi Pkhakadze
02/07/2026
Microscopic brain tumor tissue sample being analyzed by AI diagnostic system

From Weeks to Minutes: AI Achieves 95% Accuracy in Brain Tumor Classification

By
Prof. Giorgi Pkhakadze
09/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up